Codis Acquires Catalent’s Nottingham (UK) Facility

Particle Dynamics Acquires EUROAPI UK Haverhill Spray Drying Facility

June 30, 2025

Pharmaceuticals

Particle Dynamics has acquired EUROAPI UK Ltd., the operator of a commercial spray drying facility in Haverhill, United Kingdom, from EUROAPI as part of the latter’s portfolio restructuring. The deal adds spray-drying expertise and commercial-scale capacity to Particle Dynamics’ global CDMO platform and will see investment to expand capabilities and serve clinical and commercial projects.

Novo Holdings Acquires Catalent for $16.5 Billion

December 18, 2024

Healthcare Services

Novo Holdings A/S agreed to acquire Catalent, Inc. in an all-cash transaction valued at approximately $16.5 billion ($63.50 per share). The deal was later completed, and Catalent became a private company under Novo Holdings ownership; Novo Nordisk subsequently acquired Catalent’s three fill-finish sites in Italy, Indiana (USA), and Belgium.

Ardena Acquires Catalent's Somerset, New Jersey Drug Product Facility

October 14, 2024

Pharmaceuticals

Ardena, a GHO Capital-backed CDMO, has signed a definitive agreement to acquire Catalent's FDA-approved drug product manufacturing facility in Somerset, New Jersey. The acquisition — expected to close in early 2025 subject to approvals — expands Ardena's US footprint and downstream capabilities in oral solid dosage manufacturing and bioanalytical services.

Blue Wolf Capital Acquires Seven Recipharm OSD Sites and Agrees to Buy Synerlab to Create New CDMO Platform

April 2, 2024

Pharmaceuticals

Blue Wolf Capital Partners has agreed to acquire seven oral solid dosage (OSD) manufacturing and development facilities from Recipharm (located in Sweden, France and Spain) and has also agreed, subject to regulatory approvals, to acquire Synerlab, a Strasbourg-based CDMO. The transactions are intended to form a new independent CDMO platform (headquartered in the UK) that expands Blue Wolf's pharmaceutical manufacturing capabilities and commercial reach across Europe.

Catalent to Acquire Metrics Contract Services for $475 Million to Expand Oral and High-Potent CDMO Capabilities

August 9, 2022

Healthcare Services

Catalent, Inc. has agreed to acquire Metrics Contract Services (Metrics), a full-service specialty CDMO based in Greenville, North Carolina, from Mayne Pharma Group Limited for $475 million. The deal is expected to close before the end of calendar year 2023, expanding Catalent’s integrated oral solid formulation development, manufacturing, packaging, and highly potent capacity.

SK Capital Acquires Catalent's Blow‑Fill‑Seal Sterile CDMO Business (Woodstock Sterile Solutions)

March 31, 2021

Pharmaceuticals

Funds managed by SK Capital Partners completed the acquisition of Catalent Pharma Solutions' Blow‑Fill‑Seal (BFS) sterile CDMO business and relaunched the business as Woodstock Sterile Solutions. The single‑site Woodstock, Illinois operation will operate independently under new CEO Paul Josephs, supporting global pharmaceutical and biologics customers; Catalent was the seller and debt financing was provided by Cerberus Business Finance.